Evaxion A/S (EVAX) Earnings Date & Reports

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVAX is expected to report earnings to 0 cents per share on November 19

Q3'26

Est.

$-0.01

Q2'26

Est.

$-0.01

Q1'26

Missed

by $0.06

Q4'25

Missed

by $0.32

Q3'25

Beat

by $0.60

The last earnings report on August 20 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 34.14K shares outstanding, the current market capitalization sits at 29.50M.

View a ticker or compare two or three

EVAX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for EVAX